Adriana gibo Podanosque

Dr. Adriana gibo Podanosque

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
APAdriana gibo Podanosque
Adriana gibo Podanosque
JDJosé Eduardo Lutaif Dolci
José Eduardo Lutaif Dolci
CFCésar Eduardo Fernandes
César Eduardo Fernandes
AGAntônio José Gonçalves
Antônio José Gonçalves
LSLucas de Oliveira Sassi
Lucas de Oliveira Sassi
FTFernando Sabia Tallo
Fernando Sabia Tallo
SUMMARY OBJECTIVE: To develop Part II of the National Consensus Catalogue of essential psychomotor competencies and establish the minimum expected competence levels for graduating medical students across 11 clinical and diagnostic support specialties in Brazil using a modified Delphi process. METHODS: This national consensus-development study used a two-phase, two-round modified Delphi process coordinated by the Brazilian Medical Association. Preliminary specialty-specific catalogues were developed between February and June 2025 by Scientific Committees from 11 specialty societies, which also proposed the minimum expected competence level for each psychomotor competency statement. Round 1 of the modified Delphi process was conducted from August to December 2025, and Round 2 was conducted from February to June 2026. Board-certified physicians evaluated each competency-competence level combination using a five-point Likert scale. Consensus was predefined as ≥75% agreement. Statements achieving <60% agreement were excluded after Round 1, whereas those achieving 60.0–74.9% agreement were revised and reassessed in Round 2. Additional competency statements proposed during Round 1 were evaluated in Round 2. RESULTS: A total of 667 physicians participated in Round 1, and 499 completed Round 2. The preliminary catalogues comprised 346 psychomotor competency statements; 240 (69.4%) achieved consensus and 106 (30.6%) were excluded. Participants proposed 38 additional statements, of which 36 (94.7%) achieved consensus in Round 2. The Part II catalogue comprised 276 specialty-specific psychomotor competency statements, corresponding to 229 unique psychomotor competencies after harmonization. Most competency statements were classified as perform independently (n=195), followed by perform under supervision (n=62) and master the technique (n=19). CONCLUSION: This modified Delphi study established Part II of the National Consensus Catalogue of essential psychomotor competencies and minimum expected competence levels for graduating medical students, encompassing 11 clinical and diagnostic support specialties in Brazil.

12 November 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
VSVictor Daniel Santos Silva
Victor Daniel Santos Silva
DFDiorginis José Soares Ferreira
Diorginis José Soares Ferreira
MNMaria Angélica Marques Do Nascimento
Maria Angélica Marques Do Nascimento
JCJadson Galdino da Silva Costa
Jadson Galdino da Silva Costa
MSMaria Hiandra Santos Xavier Silva
Maria Hiandra Santos Xavier Silva
Irwin Rose Alencar de MenezesIrwin Rose Alencar de Menezes
Irwin Rose Alencar de Menezes
Background/Objectives: Epilepsy affects more than 50 million people worldwide, and approximately one-third of patients exhibit drug resistance to conventional treatments. In this context, terpene compounds have emerged as promising alternatives due to their neuroprotective and anticonvulsant properties. This study aimed to analyze the preclinical evidence regarding the anticonvulsant effects of compounds belonging to the terpene class in animal models of epilepsy and seizures. Methods: A systematic review and meta-analysis (PROSPERO CRD420261449697) were conducted according to the PRISMA guidelines. Searches were performed in the PubMed, Web of Science, Embase and Scopus databases. The risk of bias was assessed using the SYRCLE Risk of Bias tool. For quantitative synthesis, only studies involving rats and mice were included. Random-effects meta-analyses were performed to assess latency to the first seizure (LFS) and latency to death (LD), with subgroup analyses according to the seizure-induction model. Leave-one-out sensitivity analyses were also conducted to assess the influence of individual studies on the pooled estimates. Results: Terpene treatment significantly increased LFS in the overall analysis (standardized mean difference–SMD = 3.08; 95% confidence interval–95% CI: 2.41–3.75; p < 0.00001), although substantial heterogeneity was observed (I2 = 81%). Significant effects were also observed in the pilocarpine (PILO; SMD = 3.45; 95% CI: 2.12–4.78; p < 0.00001) and pentylenetetrazole (PTZ; SMD = 3.00; 95% CI: 2.19–3.81; p < 0.00001) models. In contrast, the pooled effect in the picrotoxin-induced model was not statistically significant (SMD = 4.02; 95% CI: 1.19 to 6.85; Z = 2.79; p = 0.005). The isoniazid-induced model also showed a significant increase in LFS, based on a single study (SMD = 10.45; 95% CI: 4.44–16.47; p = 0.0007). Substantial heterogeneity persisted in the PILO (I2 = 82%), PTZ (I2 = 77%), and picrotoxin (I2 = 90%) subgroups. In contrast, the overall analysis of LD showed no statistically significant effect (SMD = 2.76; 95% CI: −0.24 to 5.77; p = 0.07; I2 = 86%). Subgroup analysis revealed a significant increase in LD in the PTZ model (SMD = 3.25; 95% CI: 2.06–4.45; p < 0.00001; I2 = 0%), whereas no significant effect was observed in the PILO model, which showed substantial heterogeneity (I2 = 95%) and considerable instability in sensitivity analyses. Methodological assessment identified unclear risk of bias in several domains, particularly those related to allocation procedures and randomization, while funnel plot asymmetry suggested possible small-study effects; however, the limited number of studies and substantial heterogeneity precluded firm conclusions regarding publication bias. Conclusions: Terpene compounds may exert preclinical anticonvulsant effects, with the most consistent evidence observed for increased LFS, particularly in the PILO and PTZ models. However, effects on LD were not statistically significant in the overall analysis, and model-specific findings remain preliminary. Substantial heterogeneity and methodological limitations warrant cautious interpretation. Further well-designed preclinical studies are needed to clarify the compound- and model-specific consistency, safety, and mechanisms of these effects before clinical translation can be considered.